Inventage Lab Completes Phase 1 Trial of Addiction Treatment, Plans U.S. Phase 2 Study
AI 요약 정보
- Inventage Lab says phase 1 confirmed IVL3004 safety
- IVL3004 injection reactions averaged 4.3 days vs 17.2 for Vivitrol
- Inventage Lab plans FDA talks and a global phase 2 trial